ArticleslgStudy

chemistry

SCH-50971

SCH-50971 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand SCH-50971 rather than just read about it. In short: SCH-50971 is a histamine H3 receptor agonist which was under development for the treatment of anxiety disorders, gastrointestinal disorders, and migraine but was never marketed. Pharmacology The drug acts as a potent, selective, and high-affinity agonist of the histamine H3 receptor.

SCH-50971 — main illustration
SCH-50971 — illustration

Key takeaways

  • SCH-50971 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect SCH-50971 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of SCH-50971 from memory before moving on to harder problems.

Reference excerpt

SCH-50971 is a histamine H3 receptor agonist which was under development for the treatment of anxiety disorders, gastrointestinal disorders, and migraine but was never marketed.

Pharmacology The drug acts as a potent, selective, and high-affinity agonist of the histamine H3 receptor. It has negligible affinity for the histamine H1 receptor and other assessed receptors. The drug is also not a histamine H2 receptor antagonist. It has greatly improved selectivity compared to the earlier selective histamine H3 receptor agonist (R)-α-methylhistamine. The drug is orally active and shows anti-allergy effects, antimigraine effects, sedative and hypnotic effects, and hypolocomotion in animals. In terms of chemical structure, it is a cyclized pyrrolidine derivative of histamine.

Development SCH-50971 was under development by Schering-Plough. It reached the discovery or preclinical research stage of development. The development of the drug was discontinued by 2001. SCH-50971 was first described in the scientific literature by 1994.

See also BP 2.94 Cipralisant (GT-2331) GT-2203 (VUF-5296)

References

Illustrations

SCH-50971 illustration

Worked examples

Example 1 — a first encounter with SCH-50971

Start with the simplest possible case. Write down what SCH-50971 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to SCH-50971 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about SCH-50971 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of SCH-50971

In research
SCH-50971 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses SCH-50971 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
SCH-50971 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Abandoned drugs, Drugs not assigned an ATC code, Histamine agonists, so understanding it makes those chapters shorter.
In everyday life
Look for SCH-50971 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “SCH-50971” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study SCH-50971 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what SCH-50971 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain SCH-50971 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is SCH-50971 in simple terms?

SCH-50971 is a histamine H3 receptor agonist which was under development for the treatment of anxiety disorders, gastrointestinal disorders, and migraine but was never marketed. Pharmacology The drug acts as a potent, selective, and high-affinity agonist of the histamine H3 receptor.

Why does SCH-50971 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study SCH-50971?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on SCH-50971.

Tags

  • Abandoned drugs
  • Drugs not assigned an ATC code
  • Histamine agonists
  • Hypnotics
  • Imidazoles
  • Methyl compounds
  • Nervous system drug stubs
  • Pyrrolidines
  • Sedatives

Keep exploring